The world’s largest global HIV research network has embraced two new monoclonal antibodies as part of the COVID-19 outpatient study sponsored by the National Institutes…
A group of researchers out of Denmark led by Aarhus University Hospital’s infectious disease department conducted a study involving 203 COVID-19 infected patients between the…
Recent observational research at Cleveland Clinic involving employees found that once they are infected with SARS-CoV-2, the virus behind COVID-19, they are not reinfected with the…
A centerpiece of US policy on COVID-19 early treatment is the ACTIV-6 Ivermectin trial. As described in ClinicalTrials.gov, the trial will look at the effect of…
Paul Elias Alexander, PhD; Howard Tenenbaum, DDS, PhD; Parvez Dara, MD, MBA We write this brief clarion call to the FDA of the United States…
Governments around the world don’t seem to want the public to know much about the COVID-19 vaccine data, for whatever reason. While in the U.S.,…
Another brilliant corporate showcasing enterprising business prowess or yet another example of crony capitalism on display for the world to see? That’s the question many…
Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company with a portfolio of assets designed to modulate immunological pathways across a spectrum of diseases, today…
By Michael B. Goodkin MD, FACC Although a great majority of ivermectin-based studies have indicated real promise, one particular study conducted by a small trial…
Registered in the UK’s study registry PROSPERO, with their results published in the peer review medical journal Reviews in Medical Virology, a team from Indonesia’s Pelita Harapan…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
